AURORA: Ajou Univ. Repository: Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy

Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapyoa mark

Jung, Keunok ;
Ko, Deok Han ;
Jang, Jeong Yun ;
Kim, Young Rong ;
Heo, Jung Yeon ;
Kim, Yong Sung

Citations

SCOPUS

2

Citation Export

RIS(EndNote)

CSV(Excel)

XML

Publication Year: 2024-01-01

Publisher: John Wiley and Sons Inc

Citation: Cancer Communications, Vol.44, pp.173-177

Mesh Keyword: CD8-Positive T-Lymphocytes COVID-19 Humans Immunotherapy Neoplasms SARS-CoV-2

All Science Classification Codes (ASJC): Oncology Cancer Research

ISSN: 2523-3548

Language: eng

URI: https://dspace.ajou.ac.kr/dev/handle/2018.oak/33727

DOI: https://doi.org/10.1002/cac2.12497

Fulltext

Type: Letter

Funding: This work was supported by the Samsung Future Technology Center (SRFCMA1802\u201009) and the Korea Health Technology R&D Project (HR22C173402) through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare.

Show full item record

qrcode

트윗하기

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Kim, Yong Sung Image

Kim, Yong Sung김용성: College of Bio-convergence Engineering

Read More

Total Views & Downloads

File Download

There are no files associated with this item.